Driven by dual carbon principles, the p-toluenesulfonic acid industry is transforming towards high-end and green development.
Nobody expects an industry built on chemistry to suddenly grow greener overnight. Yet for those working with p-toluenesulfonic acid (PTSA), the shift from legacy processes to more sustainable ones is not just a buzzword. This change tracks back to tougher expectations on reducing carbon emissions and boosting resource efficiency. Years ago, I saw plants running on outdated energy systems where waste heat vented straight into the air, and solvent recovery looked like more of a box-check than a re...
Responding to pharma & chemical market needs, the company innovates throughout R&D, production and sales of diverse products.
Breaking new ground in the pharmaceutical and chemical world can’t rest on the same recipes. Each breakthrough drug isn’t just a lab story; it’s often years of blocked paths, reformulations, or surprise failures that usually fill the days of researchers and business folks alike. Solutions don’t spring straight from textbooks. In my own work alongside scientists and process managers, the tension stays high between chasing a new compound and getting it through scale-up without headac...
The global production capacity of p-toluenesulfonic acid is changing, with China accounting for over 50%.
Looking at how medicine gets made, I always notice how easy it is for people to talk about the “supply chain” as if it’s just shipping things from place to place. What goes ignored far too often is the real human and technical expertise every layer of that chain demands—from the first flask in a chemistry lab with a raw material, to the last tablet leaving a packaging plant. In this business, missing just one connection in research, production, or sales could send a whole project s...
